AOD-9604 is a modified form of amino acids 176-191 at the C-terminus of the human growth hormone (HGH). Designed to fight obesity and aid in weight management, it has garnered attention for its ability to stimulate lipolysis (the breakdown of fat) and inhibit lipogenesis, both of which are significant factors in weight loss and management.
Mechanism of Action
AOD-9604 exerts its effects primarily by mimicking the way natural growth hormone regulates fat metabolism without the adverse impact on blood sugar or growth that is seen with unmodified HGH. It activates the beta-3 adrenergic receptors in adipose (fat) tissues, triggering fat breakdown and release. Unlike other fat-burning compounds, AOD-9604 does not negatively impact insulin sensitivity or cell proliferation, making it a targeted option for fat loss. Additionally, it does not compete with HGH receptors, ensuring that its activity is focused on fat loss without influencing growth processes or insulin pathways.
Benefits and Uses
Enhanced Fat Loss: This is particularly effective in stimulating fat release from obese fat cells while having a minimal effect on lean muscle mass.
Regulation of Metabolism: AOD-9604 has shown potential in enhancing the body’s metabolic rate, contributing to weight management.
No Impact on Blood Sugar Levels: Unlike HGH, AOD9604 does not impair insulin sensitivity, making it safer for individuals concerned about blood sugar levels.
Potential Cartilage Regeneration: Early research indicates AOD-9604 promotes cartilage repair and regeneration, offering benefits for joint health and function.
The specific targeting of fat cells makes AOD-9604 an attractive option for those looking to reduce body fat and improve body composition without the complications associated with conventional HGH treatment.
